Notably, this sample size has been sufficient to observe significant associations between IGF1R, EZH2, and Ki67 and breast cancer risk within the same nested case–control study.23–25,29 The limited sample size also precludes adjustment for many variables, leaving the findings susceptible to possible residual confounding. Here, EZH2 is linked to breast carcinoma.